Chemical Formula: C12H21N5O3

Chemical Formula C12H21N5O3

Found 13 metabolite its formula value is C12H21N5O3

Lysylhistidine

(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-imidazol-5-yl)propanoic acid

Lysylhistidine is a dipeptide composed of lysine and histidine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

Histidyllysine

(2S)-6-amino-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]hexanoic acid

C12H21N5O3 (283.16443160000006)

Histidyllysine is a dipeptide composed of histidine and lysine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

Cadralazine

N-{6-[ethyl(2-hydroxypropyl)amino]pyridazin-3-yl}ethoxycarbohydrazonic acid

C12H21N5O3 (283.16443160000006)

C - Cardiovascular system > C02 - Antihypertensives > C02D - Arteriolar smooth muscle, agents acting on > C02DB - Hydrazinophthalazine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent Cadralazine is an antihypertensive of the hydrazinophthalazine chemical class. D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

Histidinyl-Lysine

6-Amino-2-{[2-amino-1-hydroxy-3-(1H-imidazol-5-yl)propylidene]amino}hexanoate

C12H21N5O3 (283.16443160000006)

His-lys

2-(2,6-diaminohexanamido)-3-(1H-imidazol-5-yl)propanoic acid

C12H21N5O3 (283.16443160000006)

A dipeptide formed from L-histidine and L-lysine residues.

Lys-his

6-amino-2-[2-amino-3-(1H-imidazol-5-yl)propanamido]hexanoic acid

C12H21N5O3 (283.16443160000006)

Cadralazine

N-{6-[ethyl(2-hydroxypropyl)amino]pyridazin-3-yl}ethoxycarbohydrazonic acid

C12H21N5O3 (283.16443160000006)

C - Cardiovascular system > C02 - Antihypertensives > C02D - Arteriolar smooth muscle, agents acting on > C02DB - Hydrazinophthalazine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

Uracil,6-amino-5-(2-diethylaminoacetamido)-1,3-dimethyl- (6CI)

C12H21N5O3 (283.16443160000006)

Oxtriphylline

choline thieophyllinate

C12H21N5O3 (283.16443160000006)

R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03D - Other systemic drugs for obstructive airway diseases > R03DA - Xanthines D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor

lysylhistidine

C12H21N5O3 (283.16443160000006)